
    
      -  To describe the demographic, clinical and pathological characteristics of patients
           diagnosed with locally advanced NSCLC;

        -  To describe the type of definitive therapy for locally advanced NSCLC

        -  To determine progression-free survival (PFS) after definitive therapy

        -  To estimate time to next treatment (TNT) after definitive therapy NSCLC in Brazil;

        -  To describe the patterns of recurrence/progression and treatment sequencing;

        -  To test the association of demographic, clinical and pathological characteristics with
           PFS, OS

        -  To compare the patterns of care (number of hospitalizations; visits to emergency room or
           ICU; outpatient unit visits) and outcomes between the private and public health care
           system;
    
  